- The Hidden Costs of Caregiving: What They Are and How Family Caregivers Can Manage Themby Steve Wright on November 22, 2026 at 1:36 pm
The hidden costs of caregiving can add up when families lose income or pay out-of-pocket expenses. See how families are finding help. The post The Hidden Costs of Caregiving: What They Are and How Family Caregivers Can Manage Them appeared first on Quest | Muscular Dystrophy Association.
- FDA declines to approve Capricor’s deramiocel for the treatment of Duchenneby Sheryl on November 21, 2026 at 1:35 am
Despite recognition of the tremendous unmet medical need in Duchenne muscular dystrophy, the FDA has decided that the evidence is not sufficient to approve Capricor’s deramiocel for the treatment of The post FDA declines to approve Capricor’s deramiocel for the treatment of Duchenne appeared first on CureDuchenne.
- FDA Issues Complete Response Letter for Deramiocelby Parent Project Muscular Dystrophy on November 21, 2026 at 12:57 am
Today, the FDA announced that it has issued a Complete Response Letter (CRL) for Capricor Therapeutics’ Biologics License Application (BLA) for Deramiocel (CAP-1002), the company’s cell therapy for Duchenne cardiomyopathy. This decision is devastating and… The post FDA Issues Complete Response Letter for Deramiocel appeared first on Parent Project Muscular Dystrophy.
- Beyond the Clinic: How an MDA Grant Is Helping People with ALS Access Assistive Technology Earlierby Mindy Henderson on November 20, 2026 at 6:29 pm
Temple University’s innovative approach brings hands-on technology education and personalized support into the clinic and patients’ homes. For someone living with amyotrophic lateral sclerosis (ALS), access to assistive technology can mean the difference between relying on someone else to turn on the lights and continuing to perform such activities in their home independently. Assistive technology… The post Beyond the Clinic: How an MDA Grant Is Helping People with ALS Access Assistive Technology Earlier appeared first on Quest | Muscular Dystrophy Association.
- Becoming a grandmother, and daring to dream of a future for my sonsby Betty Vertin on November 20, 2026 at 3:00 pm
When my children were little, I often wondered what their sibling relationships would be like as they got older. I hoped they would be close. My husband, Jason, and I have seven children: Lexi, 25; Max, 21; Chance, 19; Rowen, 17; Charlie, 15; Mary, 12; and Callie, 4. Max, Rowen, and Charlie have Duchenne muscular dystrophy (DMD). The post Becoming a grandmother, and daring to dream of a future for my sons appeared first on Muscular Dystrophy News.
- CureDuchenne Establishes First Adult Multidisciplinary Program at Penn Medicine to Improve Care for Adults with Duchenne or Becker Muscular Dystrophyby emilie@cureduchenne.org on November 19, 2026 at 7:04 pm
NEWPORT BEACH, Calif., November 19, 2026 – CureDuchenne, a leading global nonprofit dedicated to finding a cure and improving care for individuals with Duchenne (DMD) and Becker muscular dystrophy (BMD), The post CureDuchenne Establishes First Adult Multidisciplinary Program at Penn Medicine to Improve Care for Adults with Duchenne or Becker Muscular Dystrophy appeared first on CureDuchenne.
- PPMD Announces Levine Children’s Hospital as Certified Duchenne Care Center, Marking 40th Center in Growing Networkby Parent Project Muscular Dystrophy on November 19, 2026 at 5:34 pm
PPMD is excited to announce the expansion of its renowned Certified Duchenne Care Center (CDCC) Program with the certification of the clinic at Atrium Health Levine Children’s Hospital in Charlotte, North Carolina. The certification marks… The post PPMD Announces Levine Children’s Hospital as Certified Duchenne Care Center, Marking 40th Center in Growing Network appeared first on Parent Project Muscular Dystrophy.
- Developer scraps treatment for 2 MD types after disappointing trial resultsby Marisa Horak, MS on November 19, 2026 at 5:00 pm
Drug maker Servier announced that it is discontinuing development of its oral treatment candidate sevasemten for both Becker muscular dystrophy (BMD) and Duchenne muscular dystrophy (DMD). The announcement comes just days after top-line data, or the first results of a clinical trial, showed that sevasemten had failed to hit the main goal or key secondary goals The post Developer scraps treatment for 2 MD types after disappointing trial results appeared first on Muscular Dystrophy News.
- Senate Appropriations Bills Advance Priorities for the Duchenne and Becker Communityby Parent Project Muscular Dystrophy on November 18, 2026 at 7:47 pm
The Senate Appropriations Committee has released its FY27 spending bills, reflecting several important priorities PPMD and our advocates have worked to advance on behalf of the Duchenne and Becker community. The bills include provisions supporting… The post Senate Appropriations Bills Advance Priorities for the Duchenne and Becker Community appeared first on Parent Project Muscular Dystrophy.
- Meet the 2026 Quest Media Photo Contest Winnersby MDA Staff on November 18, 2026 at 4:15 pm
Photo contest winner Austin Puckett and his dog, Dee, share a bond. See this and more memorable photos from Quest Media readers. The post Meet the 2026 Quest Media Photo Contest Winners appeared first on Quest | Muscular Dystrophy Association.
- 6 Tips for Managing Pain and Fatigue During the Holidaysby Megan Kramer-Salvitti on November 18, 2026 at 4:01 pm
The holidays bring extra demands on your body. Experts share practical tips to manage your energy while making time for traditions that matter to you. The post 6 Tips for Managing Pain and Fatigue During the Holidays appeared first on Quest | Muscular Dystrophy Association.
- Building a Community of Support on My Journey to Advocacyby Wanzie Li on November 18, 2026 at 3:48 pm
For Wanzie Li, disability advocacy and community opened a path to belonging, self-acceptance, and a future focused on advancing access and disability rights. The post Building a Community of Support on My Journey to Advocacy appeared first on Quest | Muscular Dystrophy Association.
- Baking with Joy: Tips for Creativity and Accessibility in the Kitchen During the Holidaysby Amy Bernstein on November 18, 2026 at 3:46 pm
Accessible baking starts with tools and techniques that work for you. Chef Billy Zureikat shares energy-saving prep tips and a chocolate chip cookie recipe. The post Baking with Joy: Tips for Creativity and Accessibility in the Kitchen During the Holidays appeared first on Quest | Muscular Dystrophy Association.
- Understanding SELENON-Related Myopathyby Michelle Jackson on November 18, 2026 at 3:43 pm
Learn about SELENON-related myopathy, from symptoms and genetic testing to supportive care and early research that could help guide future treatment options. The post Understanding SELENON-Related Myopathy appeared first on Quest | Muscular Dystrophy Association.
- Progress Now: Clinical Trials and Recent Drug Approvalsby MDA Staff on November 18, 2026 at 3:41 pm
Explore research updates, including neuromuscular disease clinical trial results, studies seeking participants, and news about approved treatments. The post Progress Now: Clinical Trials and Recent Drug Approvals appeared first on Quest | Muscular Dystrophy Association.
- Key Takeaways From the 2026 Disability:IN Global Conferenceby Rebecca Hume on November 18, 2026 at 3:40 pm
Disability inclusion in business creates opportunities for employees, entrepreneurs, and consumers. Discover in-sights from the 2026 Disability:IN conference. The post Key Takeaways From the 2026 Disability:IN Global Conference appeared first on Quest | Muscular Dystrophy Association.
- James Dawson Cultivates Resilience and Adaptability as an Actorby Rebecca Hume on November 18, 2026 at 3:38 pm
James Dawson, an actor with spinal muscular atrophy, shares his journey in theater, film, and comedy and the support that helps him pursue his career goals. The post James Dawson Cultivates Resilience and Adaptability as an Actor appeared first on Quest | Muscular Dystrophy Association.
- Researchers Are Exploring Innovative Nonviral Gene Therapy Delivery Approachesby Maggie Callahan on November 18, 2026 at 3:36 pm
Several methods to deliver gene therapy without a virus look promising in research labs and may soon be ready for human clinical trials. The post Researchers Are Exploring Innovative Nonviral Gene Therapy Delivery Approaches appeared first on Quest | Muscular Dystrophy Association.
- Ripple Effect: Navigating a New Medicaid Landscapeby Matt Schur on November 18, 2026 at 3:34 pm
Medicaid changes bring uncertainty for people living with neuromuscular diseases. Learn ways to prepare, protect your coverage, and speak up for needed care. The post Ripple Effect: Navigating a New Medicaid Landscape appeared first on Quest | Muscular Dystrophy Association.
- 3 Steps for a Smooth Transition From Pediatric to Adult Care for People Living with Neuromuscular Diseasesby Amy Bernstein on November 18, 2026 at 3:32 pm
Prepare for the transition to adult care with guidance on building self-advocacy skills, finding providers, and getting support along the way. The post 3 Steps for a Smooth Transition From Pediatric to Adult Care for People Living with Neuromuscular Diseases appeared first on Quest | Muscular Dystrophy Association.
- With DMD, I’m making plans for tomorrow while preparing for goodbyeby Shalom Lim on November 18, 2026 at 3:00 pm
At 31 years old, I am managing two very different conversations about the future. With my girlfriend, Amanda, I discuss what we hope to build together. With my parents and my palliative care doctor, I discuss what should happen if I can no longer speak for myself. Both conversations concern people I love. Only one The post With DMD, I’m making plans for tomorrow while preparing for goodbye appeared first on Muscular Dystrophy News.
- Advancing the Science of Dystrophin Measurement: PPMD Hosts 2026 Dystrophin Expression Workshopby Parent Project Muscular Dystrophy on November 17, 2026 at 7:56 pm
On November 12–13, PPMD convened scientists, clinicians, industry experts, caregivers, and representatives from the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC) for the 2026 Dystrophin Expression Workshop: Harmonization… The post Advancing the Science of Dystrophin Measurement: PPMD Hosts 2026 Dystrophin Expression Workshop appeared first on Parent Project Muscular Dystrophy.
- Sarepta won’t reopen enrollment in Duchenne gene therapy trialby Michela Luciano, PhD on November 17, 2026 at 4:15 pm
Sarepta Therapeutics will not reopen enrollment in a global clinical trial testing its gene therapy Elevidys (delandistrogene moxeparvovec-rokl) in boys and men with Duchenne muscular dystrophy (DMD), the company announced in a community letter. The Phase 3 trial, called ENVISION (NCT05881408), was designed to assess Elevidys’ safety and effectiveness in late-ambulatory patients (those who can The post Sarepta won’t reopen enrollment in Duchenne gene therapy trial appeared first on Muscular Dystrophy News.
- Collaboration Between Novartis and Becoming rentABLE Is Opening More Doors to Accessible Travelby Rene Ryan on November 16, 2026 at 1:31 pm
A collaboration between Novartis and Becoming rentABLE is expanding short-term vacation rental options for travelers with disabilities. The post Collaboration Between Novartis and Becoming rentABLE Is Opening More Doors to Accessible Travel appeared first on Quest | Muscular Dystrophy Association.
- Servier ends clinical trials for sevasemten in both Becker and Duchenne muscular dystrophyby Sheryl on November 13, 2026 at 5:08 pm
After the recent and disappointing news that the GRAND CANYON study in Becker muscular dystrophy did not meet its primary or key secondary endpoints, and a Governance Committee review of The post Servier ends clinical trials for sevasemten in both Becker and Duchenne muscular dystrophy appeared first on CureDuchenne.

















